Use of biological molecules in the treatment of inflammatory bowel disease

Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy

(2010) Abderrahim Oussalah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease

(2010) Waqqas Afif et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management

(2010) Signe Larsen et al.   ANNALS OF MEDICINE

Inflammatory Bowel Disease

(2010) Arthur Kaser et al.   Annual Review of Immunology

Adverse effects of biologics used for treating IBD

(2010) Andreas Stallmach et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity

(2010) Severine Vermeire et al.   Clinical Gastroenterology and Hepatology

Anti-TNF and Crohns Disease: When Should We Stop?

(2010) Edouard Louis et al.   CURRENT DRUG TARGETS

Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review

(2010) Abderrahim Oussalah et al.   CURRENT DRUG TARGETS

Neurologic disorders associated with inflammatory bowel disease

(2010) L. Benavente et al.   EUROPEAN JOURNAL OF NEUROLOGY

The pharmacoeconomics of biologic therapy for IBD

(2010) Russell D. Cohen   Nature Reviews Gastroenterology & Hepatology

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the Tumor Necrosis Factor Antagonists

(2010) F. Bachmann et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

(2009) G. R. LICHTENSTEIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn’s disease after failure of two other anti-TNF antibodies

(2009) M. ALLEZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Use of Infliximab in Particular Clinical Settings: Management Based on Current Evidence

(2009) Alfredo Papa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Natural History of Adult Crohn's Disease in Population-Based Cohorts

(2009) Laurent Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease

(2009) Josh Marehbian et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

(2009) G R Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

(2009) J Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy

(2009) Pierre Lozeron et al.   ARCHIVES OF NEUROLOGY

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis

(2009) Sophie Martin Du Pan et al.   ARTHRITIS AND RHEUMATISM

Serum sickness, encephalitis and other complications of anti-cytokine therapy

(2009) Séverine Vermeire et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease

(2009) Lysa Boissé et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Certolizumab pegol for the management of Crohn's disease in adults

(2009) Anastasia Rivkin   CLINICAL THERAPEUTICS

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

(2009) Konstantinos Karmiris et al.   GASTROENTEROLOGY

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Predicting the response to infliximab from trough serum levels

(2009) P. Rutgeerts et al.   GUT

Adalimumab for the treatment of fistulas in patients with Crohn's disease

(2009) J-F Colombel et al.   GUT

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

(2009) C H Seow et al.   GUT

Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohnʼs disease population

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France

(2009) Jean-Baptiste Chevaux et al.   INFLAMMATORY BOWEL DISEASES

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Rheumatoid arthritis

(2009) Lars Klareskog et al.   LANCET

IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab

(2009) Charlotte Magdelaine-Beuzelin et al.   Pharmacogenetics and Genomics

Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

(2009) Klaus Bendtzen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Diagnosis and management of fistulizing Crohn's disease

(2009) Ole Haagen Nielsen et al.   Nature clinical practice. Gastroenterology & hepatology

Treatment of Recurrent Crohn's Uveitis With Infliximab

(2008)   AMERICAN JOURNAL OF GASTROENTEROLOGY

Cancer risks in Crohn disease patients

(2008) K. Hemminki et al.   ANNALS OF ONCOLOGY

Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

(2008) T R D J Radstake et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

(2008) J.P. Gisbert et al.   DIGESTIVE AND LIVER DISEASE

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

(2008) Brian G. Feagan et al.   GASTROENTEROLOGY

Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial

(2008) Gert Van Assche et al.   GASTROENTEROLOGY

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Hepatosplenic T cell lymphoma in inflammatory bowel disease

(2008) M. Shale et al.   GUT

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT

Does smoking decrease the response to infliximab in patients with Crohnʼs disease?

(2008) Mansour A. Parsi   INFLAMMATORY BOWEL DISEASES

Treatment of choice for acute severe steroid-refractory ulcerative colitis is Remicade

(2008) Jonas Halfvarson et al.   INFLAMMATORY BOWEL DISEASES

Effects of light smoking consumption on the clinical course of Crohnʼs disease

(2008) Philippe Seksik et al.   INFLAMMATORY BOWEL DISEASES

The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies

(2008) George E. Reese et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET

Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease

(2007) Mark A. Ainsworth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY